Skip to main content
. Author manuscript; available in PMC: 2020 Oct 19.
Published in final edited form as: Front Cell Dev Biol. 2020 Sep 30;8:523550. doi: 10.3389/fcell.2020.523550

Figure 3. ULK1 loss suppresses the expression of human cholesterogenic genes.

Figure 3

(A,B) Representative immunoblot showing KD efficiency of ULK1 and RNA-seq derived transcriptomic pathway analysis in HepG2 cells treated with ± Ulk1 siRNA (Thermo Fisher Scientific, s15965; 10 nM/72 h). (C) qRT-PCR validation of mevalonate/cholesterol biosynthesis pathway genes ± Ulk1 siRNA (10 nM/72 h) in HepG2 cells. Values are means ± SD (n = 4), p < 0.05.